CFTR and hereditary disease: CFTR functional recovery by the AsCas12a single crRNA strategy is validated in intestinal organoids derived from CF patients carrying the 3272-26A>G or the 3849+ 10kbC>T mutations, thus highlighting the power of this approach for the permanent correction of genetic diseases caused by deep intronic splicing mutations.